FIELD: medicine.
SUBSTANCE: morphological changes of patient's retina and degree of changes of thresholds of macular zone (MZ) light sensitivity, level of glycosylated haemoglobin (G) in patient's blood plasma, levels of vascular endothelium growth factor (VEGF) and monocyte chemoattractant protein-1 (MCP-1) in lacrimal fluid are determined. On this basis obtained are criteria R1-R5, differentially determining patient's eye fundus condition, where R1 characterises expression of oedema on retina volume, R2 -degree of change of thresholds of MZ light sensitivity, taking into account light stimulus intensity, R3 - interaction between retina changes and degree of DM compensation, characterised by blood G level, R4 - interaction between retina changes and VEGF level in lacrimal fluid, R5 - interaction between retina changes and MCP-1 level in lacrimal fluid. Virtual areas of parameters of normal eye fundus condition for groups of criteria: R1, R3, R4, R5 and R2, R3, R4, R5 are formed by preliminarily determined values of criteria R1-R5, corresponding to normal eye fundus condition. Values of the same criteria, obtained from the patient, are used to build regression lines for the same groups of criteria: R1, R3, R4, R5 and R2, R3, R4, R5, characterising current condition of patient's eye fundus. After that, respective formed areas of existing of normal eye fundus condition parameters and regression lines of current condition of patient's eye fundus are superposed. By the data of position of points of crossing of respective formed areas and regression lines criteria R1tot and R2tot are determined. After that criterion Restimation is calculated by formula; Restimation = √A, where A = R2 1tot + R2 2tot. If Restimation is < 0.5, condition of eye fundus is estimated as unsatisfactory and requiring medicinal procedures. If Restimation is > 0.5, eye fundus condition is considered to be satisfactory.
EFFECT: objective complex diagnostic approach, taking into account interaction of morphological, clinical-and-functional and biochemical indices, accurate estimation of eye fundus condition in case of said combined pathology of patient, detection of risk of disease progressing.
6 cl, 8 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF PROGRESSION OF DIABETIC RETINOPATHY AND DIABETIC MACULAR OEDEMA | 2013 |
|
RU2520826C1 |
METHOD FOR EARLY DIAGNOSTICS AND PREDICTION OF DIABETIC AND HYPERTENSIVE RETINOPATHY PROGRESSING IN CASE OF COMBINED COURSE OF TYPE 2 DIABETES MELLITUS AND HYPERTENSIVE DISEASE | 2015 |
|
RU2610535C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF DIABETIC RETINOPATHY IN THE POSTOPERATIVE PERIOD OF COMBINED KIDNEY AND PANCREAS TRANSPLANTATION | 2021 |
|
RU2785270C1 |
METHOD OF PREDICTION OF PROGRESSION OF OPEN-ANGLE GLAUCOMA IN COMBINATION WITH DIABETIC RETINOPATHY IN PATIENTS WITH DIABETES | 2015 |
|
RU2603300C1 |
METHOD FOR PREDICTING THE DEVELOPMENT OF DIABETIC RETINOPATHY IN PATIENTS WITH GERIATRIC SYNDROMES | 2022 |
|
RU2779940C1 |
TREATMENT OF EYE DISEASES SUCH AS MACULAR DEGENERATION, GLAUCOMA AND DIABETIC RETINOPATHY WITH MEDICATIONS THAT ELIMINATE AGING CELLS | 2018 |
|
RU2815482C2 |
NEUTRAL ENDOPEPTIDASE (NEP) AND SOLUBLE HUMAN ENDOPEPTIDASE (SHE) INHIBITORS FOR PREVENTION AND TREATMENT OF EYE DISEASES | 2019 |
|
RU2758771C1 |
METHOD FOR THE DIFFERENTIAL DIAGNOSIS OF MELANOMA OF THE CHOROID OF THE CENTRAL LOCALIZATION AND THE LATE STAGE OF AGE-RELATED MACULAR DEGENERATION | 2022 |
|
RU2792554C1 |
DERIVATIVES OF N-UREA-SUBSTITUTED AMINOACIDS AS MODULATORS OF FORMYL-PEPTIDE RECEPTOR | 2014 |
|
RU2696581C2 |
METHOD FOR PREDICTING CLINICAL MANIFESTATIONS OF DIABETIC RETINOPATHY IN II TYPE DIABETES PATIENTS | 2005 |
|
RU2292549C1 |
Authors
Dates
2015-09-27—Published
2014-05-22—Filed